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Abstract
Background: Advancements in Next Generation Sequencing (NGS) technologies regarding throughput, read length
and accuracy had a major impact on microbiome research by significantly improving 16S rRNA amplicon sequencing.
As rapid improvements in sequencing platforms and new data analysis pipelines are introduced, it is essential
to evaluate their capabilities in specific applications. The aim of this study was to assess whether the same
project-specific biological conclusions regarding microbiome composition could be reached using different
sequencing platforms and bioinformatics pipelines.
Results: Chicken cecum microbiome was analyzed by 16S rRNA amplicon sequencing using Illumina MiSeq,
Ion Torrent PGM, and Roche 454 GS FLX Titanium platforms, with standard and modified protocols for library
preparation. We labeled the bioinformatics pipelines included in our analysis QIIME1 and QIIME2 (de novo
OTU picking [not to be confused with QIIME version 2 commonly referred to as QIIME2]), QIIME3 and QIIME4
(open reference OTU picking), UPARSE1 and UPARSE2 (each pair differs only in the use of chimera depletion
methods), and DADA2 (for Illumina data only). GS FLX+ yielded the longest reads and highest quality scores,
while MiSeq generated the largest number of reads after quality filtering. Declines in quality scores were observed
starting at bases 150–199 for GS FLX+ and bases 90–99 for MiSeq. Scores were stable for PGM-generated data. Overall
microbiome compositional profiles were comparable between platforms; however, average relative abundance of
specific taxa varied depending on sequencing platform, library preparation method, and bioinformatics analysis.
Specifically, QIIME with de novo OTU picking yielded the highest number of unique species and alpha diversity
was reduced with UPARSE and DADA2 compared to QIIME.
Conclusions: The three platforms compared in this study were capable of discriminating samples by treatment,
despite differences in diversity and abundance, leading to similar biological conclusions. Our results demonstrate
that while there were differences in depth of coverage and phylogenetic diversity, all workflows revealed comparable
treatment effects on microbial diversity. To increase reproducibility and reliability and to retain consistency between
similar studies, it is important to consider the impact on data quality and relative abundance of taxa when selecting
NGS platforms and analysis tools for microbiome studies.
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Background
Sequencing of 16S rRNA amplicons is now a well-
established and robust method used in compositional
studies of the gut microbiome of humans, animals, and
insects. These studies have generated a wealth of infor-
mation regarding the impact of diet [1–4], disease [5–7],
antibiotics [8], probiotics [9–11], prebiotics [12, 13] and
environmental exposures [14] on the microbiota, while
simultaneously permitting the identification of new bac-
teria [15]. However, the excitement of applying these
emerging technologies to new and important research
questions has relegated important technical consider-
ations affecting comparisons between research done by
different laboratories following different protocols. Given
the importance of NGS technologies on microbiome
research, comparative studies focusing on different plat-
forms are essential to confirm or refute published data.
Early microbiome studies focused on quality control,
aimed to reduce sequencing error by bioinformatically re-
moving chimeras and other sequencing artifacts from 16S
rRNA amplicon sequences generated by pyrosequencing
[16]. Later, studies have compared data output from differ-
ent sequencing platforms applied to genome [17–19] and
16S rRNA amplicon sequencing [20, 21]. While bioinfor-
matics tools like removal of chimeric sequences can re-
duce some of the intrinsic errors of sequencing data, it is
challenging to eliminate the bias introduced by primer
design [22], library preparation [23], DNA isolation
methods [24], and PCR amplification artifacts, each of
which introduce unique biases that can result in over or
underrepresentation of individual microbes within com-
plex communities [25]. These biases are unavoidable and
rarely impact the overall merit of a study.
Collective concerns regarding methodological biases
and the ability to compare studies from different re-
search groups originated a collaborative effort designed
to comprehensively evaluate methods employed in the
study of the human microbiome, the Microbiome Qual-
ity Control project (MBQC). Inspired by earlier projects
like the Microarray Quality Control project (MAQC),
the MBQC focused on the analyses of the impacts of
sample collection, DNA extraction, sequencing protocol,
and bioinformatics data analysis pipelines on amplicon
profiling of the human fecal microbiome. Although the
coalition is still in early stages, the MBQC has identified
the DNA isolation method (and the lab performing the
DNA isolation), as well as 16S rRNA amplification
primers used, as major sources of variation, while se-
quencing depth and sample storage had small but de-
tectable effects on the generated data [26].
A number of recent studies have attempted to identify
errors or bias generated by the intrinsic characteristics of
sequencing platforms [18, 27, 28]. Performance compari-
sons between sequencing platforms and bioinformatics
pipelines indicate that Roche GS FLX+, Illumina MiSeq,
and Ion Torrent PGM are capable of generating high
quality, comparable data [22, 29–31]. In one study, the
performance of Ion Torrent PGM, Pacific Biosciences RS
and Illumina MiSeq platforms was compared on genome
sequencing of 4 bacterial strains with different GC con-
tents [17]. Although all three platforms provided sufficient
depth and resolution, there were biases present in each
platform. PGM yielded deep coverage for GC-rich se-
quences but was biased for AT-rich sequences coverage.
PacBio and MiSeq demonstrated equivalent coverage of
GC- and AT-rich sequences [17], but had varying error
rates prior to assembly [32]. A different study compared
the performances of Illumina GA II and Roche GS FLX+
using the same DNA samples obtained from a complex
freshwater planktonic community. The platforms showed
comparable total diversity; however, more homopolymer
errors were identified with the Roche GS FLX+ platform
compared to GA II which generated longer and more ac-
curate contigs [18]. Finally, a comparison of the healthy
skin microbiome using the Illumina MiSeq and Roche GS
FLX+ platforms showed that sequencing data from the
V3-V4 16S rRNA hypervariable region were concordant
between replicates, and between platforms indicating that
the method and platforms were comparable for determin-
ing skin microbiota [33].
Further comparative studies between Ion Torrent PGM,
Illumina MiSeq, Illumina HiSeq, and Roche GS FLX+
confirmed that the later generated the longest reads
among these platforms (up to 600 bp) but had a relatively
high error rate with poly-bases of more than 6 base pairs
[27]. Additionally, sequencing runs on Roche GS FLX+
had a higher cost and lower throughput than the Illumina
platform. Conversely, the Illumina platform had the fastest
run time and highest throughput, up to 13.5 Gb on the
MiSeq PE300, but relatively high frequency of substitution
errors and shorter reads compared to GS FLX+ [34]. Run
time and homopolymer error rates for the Ion Torrent
PGM platform was substantially lower compared to the
Roche GS FLX+ platform but yielded a lower throughput,
shorter reads and lower quality scores [35].
Together, the previously discussed data indicate that
technical protocols and sequencing platforms have a
variable impact on output. In this study, we report a
comparison of the three most widely utilized sequencing
platforms: Illumina MiSeq, Ion Torrent PGM, and
Roche 454 GS FLX+, using the most current library
preparation protocols and sequencing kits available for
16S rRNA amplicon sequencing. Although Roche dis-
continued support for the 454 GS FLX+ sequencing
platform in 2016, the platform still has relevance to
studies that have used this technology in the past or any
ongoing studies that may utilize a sequencing provider
whom is still running the 454 GS FLX+ sequencer. More
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importantly, this study couples the platform comparison
with a systematic assessment of bioinformatics pipelines
commonly used for amplicon data analysis: Quantitative
Insights Into Microbial Ecology (QIIME) [36] and
UPARSE [37] with or without chimera detection
methods, based either on de novo OTU picking or open
reference OTU picking. Although a relatively recently
developed tool that has not been extensively tested for
accuracy and efficacy, we have also included DADA2
[38] and a comparator method in our analysis in order
to assess the effectiveness of bioinformatic analysis at a
finer level than the traditional 97% similarity threshold.
Fourteen cecum samples randomly selected from an
ongoing study aiming to investigate the impact of vac-
cination against Salmonella and prebiotic supplementa-
tion on the chicken gut microbiome and immune
responses were used in this study. We have previously
shown that prebiotics have a modulatory effect on the
gut microbiome [13, 39], not by dramatically altering its
composition but by impacting very specific bacterial
groups. Hence, we chose to include in our comparison
of bioinformatics pipelines methods without chimera re-
moval in order to determine if specific groups known to
be altered by the prebiotic (Bifidobacterium, Lactobacil-
lus) were impacted by this additional step. Clearly, the
utility of chimera removal has been widely demonstrated
in the analysis of 16S rRNA amplicon sequencing data
[40, 41].
The aim of the present study was to explore influences
of sequencing platforms and bioinformatics pipelines on
diversity and relative abundance of bacterial taxa in 16S
rRNA amplicon data. Additionally, each platform and
analysis pipeline was compared for their abilities to dis-
criminate between samples from various treatment
groups in order to validate their functionality in micro-
biome studies.
Methods
Samples and DNA isolation
The same physical samples were used for all sequencing
experiments across platforms and bioinformatics pipe-
lines. Total genomic DNA was extracted using E.Z.N.A.
Stool DNA Kit (Omega Bio-Tek, Norcross, GA) according
to manufacturer’s instructions with minor modifications.
Briefly, 200 mg of intestinal content were added to a tube
containing 540 μl of SLB buffer and 200 mg of glass beads.
Samples were homogenized using a TissueLyser (Qiagen,
Germantown, MD) for 5 min at 30 Hz in 1 min intervals
between bead beating and ice incubation cycles. DS buffer
and proteinase K were added according to the manufac-
turer’s instruction. The mix was incubated at 70 °C for
10 min, followed by another incubation at 95 °C for
5 min. Quality of the isolated DNA was assessed by agar-
ose gel electrophoresis and purity verified using 260/280
and 260/230 ratios measured by NanoDrop 1000 instru-
ment (Thermo Fisher Scientific, Waltham, MA). DNA
concentration was quantified using Quant-iT™ PicoGreen
dsDNA Reagent (Molecular Probes, Thermo Fisher Scien-
tific division, Eugene, OR).
454 Genome sequencer FLX+ 16S rRNA amplicon
sequencing
Protocols for preparation of libraries for sequencing are
represented in Fig. 1. Initial amplification of the hypervari-
able V1-V2 region of the bacterial 16S rRNA was per-
formed on total DNA from collected samples as
previously described [1, 13, 42]. Reaction master mixes
contained the Qiagen Hotstar Hi-Fidelity Polymerase kit
reagents (Qiagen, Valencia CA) with a forward primer
composed of the Roche Titanium Fusion Primer A (se-
quencing primers used in this study are listed in Table 1) a
10 bp Multiplex Identifier (MID) sequence (Roche, In-
dianapolis, IN), unique to each of the samples, and the
universal bacterial primer 8F [43]. The reverse primer was
composed of the Roche Titanium Primer B, the identical
10 bp MID sequence, as the forward primer, and the re-
verse bacterial primer 338R [44]. Negative controls, not
containing template, were amplified for all barcode-
primer sets. Each sample was gel purified individually
using the E-Gel Electrophoresis System (Life Technolo-
gies, Thermo Fisher Scientific division, Grand Island, NY)
and standardized prior to pooling. The 16S rRNA ampli-
cons were sequenced on a 454 Genome Sequencer FLX+
system instrument (Roche, Indianapolis, IN) at the Micro-
biome Core Facility, (University of North Carolina, Chapel
Hill, NC) using the GS FLX Titanium XLR70 sequencing
reagents and corresponding protocol. Initial data analysis,
base pair calling and trimming of each sequence to yield
high quality reads, were performed by Research Comput-
ing at the University of North Carolina at Chapel Hill.
Illumina MiSeq 16S rRNA amplicon sequencing
DNA was amplified using primers targeting the V1-V2
region of the bacterial 16S rRNA gene [15, 43] and over-
hang adapter sequences appended to the primer pair for
compatibility with Illumina index and sequencing
adapters. The complete sequences of the primers are
listed in Table 1. Master mixes contained 12.5 ng of total
DNA and 2× KAPA HiFi HotStart ReadyMix (KAPA
Biosystems, Wilmington, MA). Negative controls, not
containing template, were amplified for all barcode-
primer sets. Each 16S amplicon was purified using
AMPure XP reagent (Beckman Coulter, Brea, CA). In
the next step each sample was amplified using a limited
cycle PCR program, adding Illumina sequencing
adapters and dual- index barcodes (index 1(i7) and index
2(i5)) (Illumina, San Diego, CA) to the amplicon target.
The final libraries were again purified using AMPure XP
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reagent (Beckman Coulter), quantified and normalized
prior to pooling. The DNA library pool was then dena-
tured with NaOH, diluted with hybridization buffer and
heat denatured before loading on the MiSeq reagent
cartridge (Illumina) and on the MiSeq instrument (Illu-
mina). Automated cluster generation and paired-end
sequencing with dual reads were performed according to
the manufacturer’s instructions.
Ion torrent PGM 16S rRNA amplicon sequencing
For amplicon library preparation the V1-V2 hypervari-
able region of the 16S rRNA gene was amplified from
Table 1 Primer sequence information for all platforms
Platform Primer Name Sequence (5′ -3′) Targeting
Region
Roche 454 Roche Titanium Fusion Primer A CCATCTCATCCCTGCGTGTCTCCGACTCAG V1-V2
Universal Bacterial Primer 8F AGAGTTTGATCCTGGCTCAG V1-V2
Roche Titanium Primer B CCTATCCCCTGTGTGCCTTGGCAGTCTCAG V1-V2
Reverse Bacterial Primer 338R GCTGCCTCCCGTAGGAGT V1-V2
Illumina
MiSeq
Forward Primer TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGAGTTTGATCCTGGCTCAG V1-V2
Reverse Primer GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGCTGCCTCCCGTAGGAGT V1-V2
Ion Torrent
PGM
Forward Primer composed of Ion Torrent adapter
A
CCATCTCATCCCTGCGTGTCTCCGACTCAG V1-V2
Universal Bacterial Primer 8F AGAGTTTGATCCTGGCTCAG V1-V2
Reverse Primer of Ion Torrent trP1 adapter CCTCTCTATGGGCAGTCGGTGAT V1-V2
Reverse Bacterial Primer 338R GCTGCCTCCCGTAGGAGT V1-V2
Fig. 1 Schematic of the experimental design of this study to test impact of library preparation methods and protocols on diversity and relative
abundance of bacteria. Protocol steps are indicated on the left. Standard methods are in black boxes while non-standard methods with modified
conditions are shown in grey boxes
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total bacterial DNA using the forward primer composed
of Ion Torrent adapter A, a 10 bp IonXpress ™ barcode
(Life Technologies, Thermo Fisher Scientific division,
Grand Island, NY), unique to each sample and the uni-
versal bacterial primer 8F. The reverse primer consisted
of Ion Torrent trP1 adapter followed by reverse bacterial
primer 338R. PCR reactions contained 50 ng of DNA
template, 2.5 units of HotStar Hi-fidelity DNA polymer-
ase (Qiagen, Valencia, CA), 1× HotStar Hi-Fidelity PCR
buffer containing dNTPs, and 0.6 μM of each primer.
Negative controls, not containing template, were ampli-
fied for all barcode-primer sets. The PCR products were
gel purified individually using the E-Gel Electrophoresis
System. DNA concentrations were quantified using
Quant-iT™ PicoGreen® dsDNA Reagent (Molecular
Probes, Thermo Fisher Scientific division, Eugene, OR)
and mixed at equimolar concentrations. Template-
Positive Ion OneTouch™ 200 Ion Sphere™ Particles were
prepared from library pool using the Ion OneTouch™ 2
system (Life Technologies, Thermo Fisher Scientific div-
ision, Grand Island, NY). The prepared templates were
sequenced on the Ion Torrent PGM instrument (Life
Technologies) in the Microbiome Core Facility using the
Ion PGM 400 sequencing reagents. All kits were used
according to the manufacturer’s instructions. Initial data
analysis, base pair calling and trimming of each se-
quence was performed on Ion Torrent browser to yield
high quality reads.
Modifications to the library preparation methodologies
The library preparation protocol for the three evaluated
sequencing platforms is depicted in Fig. 1. The Illumina
amplification protocol for 16S rRNA amplicon gener-
ation has 25 cycles at 55 °C annealing temperature, while
the protocol used in this study for barcoding and library
preparation for 454 and Ion Torrent has 10 more cycles
and 5 degrees less in the annealing temperature step of
the PCR reaction. Therefore, we decided to evaluate
modifications of the PGM library preparation protocol
to determine if these differences had an impact on diver-
sity and taxa composition of samples. Consequently, for
the second PGM run (PGM2) we maintained the same
annealing temperature (50 °C) but reduced the number
of cycles to 25 and for the third PGM run (PGM3) we
maintained the number of cycles (35 cycles) but in-
creased the annealing temperature to 55 °C.
Bioinformatics analysis
Roche 454 sequencing results were initially processed
using GS Data Analysis Software package [45]. The three
Ion Torrent sequencing runs (PGM1, PGM2 and
PGM3) were initially processed using the onboard data
analysis software of the Ion PGM [46]. The two Illumina
sequencing runs (MiSeq1 and MiSeq2) were converted
to multiplexed fastq format using CASAVA 1.8.2 [47].
Paired-end reads from the Illumina platform were joined
using the QIIME 1.8.0 [36] invocation of fastq-join [48].
Bioinformatic analysis of bacterial 16S rRNA amplicon
data was conducted using the QIIME software pipeline
[36] and as described [42]. The combined six raw se-
quencing data plus metadata describing the samples
were de-multiplexed and filtered for quality control. Se-
quences were aligned and clustered into operational
taxonomic units (OTU) based on the de novo OTU
picking algorithm using the QIIME implementation of
UCLUST [49]. After OTU picking step [49], chimeras
and singletons were removed using ChimeraSlayer [40,
50]. After taxonomic assignation of OTUs, sequences
were aligned and phylogenetic trees were built with Fas-
tTree 2.1.3 [51]. OTUs with 97% similarity level were se-
lected for taxonomical assignment and employed for
diversity (Shannon index) and richness analysis. Beta di-
versity estimates were calculated within QIIME using
weighted and unweighted Unifrac distances [52] between
samples at a sub-sampling depth of 1000 sequences per
sample. From these estimates, jackknifed principal coor-
dinates were computed to compress dimensionality into
two- and three-dimensional principal coordinate analysis
plots. QIIME was also used to calculate alpha diversity
with a sub-sampling depth of 1000 using observed
species, Shannon and phylogenetic diversity (PD) met-
rics. To evaluate the similarities between bacterial
communities a principal coordinate analysis (PCoA)
using Unweighted and Weighted Fast Unifrac [52, 53]
was performed to compare samples based on their
treatment.
In addition to the primary bioinformatics pipeline,
additional pipelines were applied. The first pipeline was
based on the de novo OTU picking algorithm as imple-
mented in QIIME 1.8.0 [49] as the primary bioinformat-
ics pipeline however in this pipeline chimeras were not
removed. The second and third pipelines were based on
open reference OTU picking as implemented in QIIME
1.8.0 [49] and differ only in the use of ChimeraSlayer
[40, 50]. The fourth and fifth pipeline was based on
UPARSE [37] and differ only in the use of chimera de-
tection. The different bioinformatics pipelines were
named as follows; QIIME1 refers to the pipeline based
on the de novo OTU picking without chimera checking,
QIIME2 (not to be confused with QIIME version 2 com-
monly referred to as QIIME2), the de novo OTU picking
pipeline with chimera detection, QIIME3 refers to the
open reference OTU picking pipeline without chimera
checking, and QIIME4 the open reference OTU picking
pipeline with chimera detection. In addition, two pipe-
lines based on UPARSE were used: UPARSE1 with
chimera detection and UPARSE2 without chimera
checking (Fig. 2).
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Restricting consideration to the two Illumina MiSeq
platform results, two pipelines intended to assess micro-
bial communities at a finer resolution than the trad-
itional 97% similarity threshold were considered. The
software package DADA2 [38] was used to produce a se-
quence table to be compared to an OTU table produced
from QIIME de novo OTU picking with a similarity
threshold of 99% from which chimeric sequences and
singleton OTUs were filtered. Assignment of taxonomy
was performed on each table using both the DADA2
taxonomy classification method and the QIIME tax-
onomy classification method. Beta diversity and procrus-
tes analysis were applied to the results of both
approaches for comparison. The non-phylogenetic Bray-
Curtis metric was used for calculation of beta diversity.
PhyloToAST [54] analysis was performed on data and
visualized using the Interactive Tree of Life (iTol) v3
[55].
Statistical analyses
Analysis of variance (ANOVA) was used to identify sig-
nificant differences in phylogenetic diversity (PD) and
species richness (S) indexes. Analysis of Similarities
(ANOSIM) and Permutational Multivariate Analysis of
Variance (PERMANOVA) analyses were applied to Un-
weighted Unifrac similarity matrices to compute similar-
ities between groups. The Kruskal Wallis test for
multiple pairwise comparisons was performed to evalu-
ate significant differences in relative abundances of bac-
terial taxa using JMP genomics (SAS, JMP Genomics
10.0). In all analyses alpha was set at 0.05.
Results
Samples from this study are from a Salmonella challenge
study conducted in poultry. The parent study aimed to
evaluate the impact of an attenuated Salmonella strain
on the gut microbiota of poultry, and to determine its
effect on the gut microbiome and efficacy on Salmonella
infection clearance after challenge. A secondary object-
ive was to determine how prebiotics modify the struc-
ture of the gut microbiome, and the impact of this
modification on Salmonella infection clearance (Azca-
rate-Peril et al., in preparation). In the current study,
analysis of microbiome composition was conducted on
14 chicken cecum samples randomly selected from 3 dif-
ferent groups: 1) control group, 2) Salmonella-vacci-
nated group, and 3) prebiotics-fed group. Each of the
groups was assigned also to two subgroups according to
a Salmonella challenge. Table 2 lists the characteristics
of each sample. In order to compare platforms perform-
ance and bioinformatics analysis pipelines, total DNA
from samples was amplified with primers targeting the
V1-V2 hypervariable region of the 16S rRNA gene and
sequenced using the GS FLX+ (Roche), Ion Torrent
PGM or Illumina MiSeq platforms according to the
scheme shown in Fig. 1. A summary of expected sequen-
cing output, reads length, and quality scores from the
three platforms is presented in Table 3. The GS FLX+
run produced the lowest number of raw reads (1/8 of a
plate) compared to PGM (314X chip) and MiSeq (one
lane); however, quality scores were higher in comparison
to both PGM and MiSeq platforms (Table 4). Quality
scores were more stable over the read length for the
Fig. 2 Evaluated bioinformatics pipelines using QIIME [36] and UPARSE [37] using two different OTU picking methods (QIIME only) either with or
without chimera removal steps
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PGM instrument while we observed a decline starting at
bases 150–199 for the GS FLX+ run and at bases 90–99
for the MiSeq run. After filtering (length > 200 bp, qual-
ity scores >25), 96% of the GS FLX+ reads, 91.8% of the
MiSeq, but only 14.9% of the PGM platform reads were
suitable for further analysis. However, the filtered num-
ber of reads for this platform and sequencing chip was
within the manufacturer’s indicated output (≈ 80,000–
100,000 reads/314X chip).
UPARSE reported a lower phylogenetic diversity than
both de novo QIIME and open reference QIIME pipelines
regardless of the sequencing platform
The bioinformatics analysis pipelines used in our study
to determine the taxonomic composition and bacterial
diversity of 14 chicken cecum samples using three differ-
ent platforms are depicted in Fig. 2. Rarefaction analyses
at an even sampling depth of 1000 reads/sample were
conducted to determine Phylogenetic Diversity (PD) and
Table 2 Characteristics of samples used in this study
Sample Intestinal Location Treatment Chicken Salmonella-challenged Time point (week)
M848A Cecum Control 7 Yes 7
M480A Cecum Vaccinated 1 No 6
M736A Cecum Vaccinated 2 No 9
M572A Cecum Vaccinated 3 No 7
M576A Cecum Vaccinated 4 No 7
M988A Cecum Vaccinated 2 Yes 8
M908A Cecum Vaccinated 3 Yes 7
M368A Cecum Prebiotics 1 No 5
M452A Cecum Prebiotics 1 No 6
M620A Cecum Prebiotics 1 No 8
M704A Cecum Prebiotics 1 No 9
M540A Cecum Prebiotics 2 No 7
M464A Cecum Prebiotics 4 No 6
M884A Cecum Prebiotics 4 Yes 7
Table 3 GS FLX (Roche), PGM (Ion Torrent, Life Technologies) and MiSeq (Illumina) platform comparison. Data was obtained from
the corresponding platform’s website
Roche 454 Ion Torrent Illumina MiSeq
Sequencing Kit GS FLX Titanium XLR70 PGM 400 Sequencing MiSeq Reagent Kits v2
Expected Read
Length
Up to 600 bp Up to 400 bp MiSeq Reagent Kit v2: Up to 2 × 250 bp
Typical
Throughput
450 Mb Ion 314™ Chip v2: Up to 100 Mb
Ion 316™ Chip v2: Up to 1 Gb
Ion 318™ Chip v2: Up to 2 Gb
Up to 8.5 Gb
Reads per Run ~1000,000 shotgun,
~700,000 amplicon
Ion 314™ Chip v2: 400–550 thousand
Ion 316™ Chip v2: 2–3 millions
Ion 318™ Chip v2: 4–5.5 millions
~15 million reads
Consensus
Accuracy
99.995% 99% 99%
Run Time 10 h Ion 314™ Chip v2: 2.3
to 3.7 h
Ion 316™ Chip v2: 3.0
to 4.9 h
Ion 318™ Chip v2: 4.4
to 7.3 h
4 h and
approximately 39 h
depending on the
number of cycles
Sample Input gDNA, cDNA, or amplicons
(PCR products)
gDNA, cDNA, or amplicons
(PCR products)
gDNA, cDNA, or amplicons
(PCR products)
Small genome, amplicon, and targeted gene panel
sequencing
Weight 532 lbs. (242 kg) 65 lbs. (30 kg) 120 lbs. (54.5 kg)
Instrument cost ~$500 K ~ $80 k ~ $125 k
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Species Richness (S) of samples (Fig. 3a and b, Add-
itional file 1: Table S1). PD values were lower for all plat-
forms when UPARSE pipelines were applied to data
compared to both de novo QIIME pipelines and open
reference QIIME pipelines (Fig. 3a). A similar observa-
tion in the case of de novo OTU picking was previously
reported by Pylro et al. [56]. In contrast, S values were
comparable between all bioinformatics pipelines (Fig. 3b).
Statistically significant differences in pairwise compari-
sons between platforms and all bioinformatics pipelines
are summarized in Fig. 3, right panels. In general terms,
diversity values for GS FLX+ compared to the MiSeq
runs were significantly different, while diversity values
for the PGM1 platform (the PGM standard method)
were not significantly different to data generated using
the MiSeq platform. The non-standard PGM2 and
Table 4 Comparative summary of sequencing depth, reads length, and quality between GS FLEX, PGM, and MiSeq platforms
Platform Raw
reads
Filtered
readsa
Mean Length after
filtering (bp)
Percentage of reads kept
after filtering
Mean quality score before
quality filtering
Number of
identified OTUs
Roche 454 118,018 113,306 377 96% 37.7 1028
Ion Torrent
PGM
481,593 71,652 297 14.9% 23.4 2747
Illumina
Miseq
4,149,441 3,811,042 334 91.8% 37.5 3731
aNumber of reads after filtering, reads of less than 200 nucleotides and with quality scores below 25 were removed
Significantly different (p<0.05)
Not significantly different (p>0.05)
GSFLEX MiSeq1 0.015 0.06 0.18 0.015 0.015 0.015
GSFLEX MiSeq2 0.03 0.075 0.075 0.03 0.015 0.03
MiSeq1 MiSeq2 1 1 1 1 1 1
PGM1 MiSeq2 0.135 0.06 0.69 1 0.555 1
PGM1 MiSeq1 0.06 0.12 1 0.645 0.045 0.105
PGM1 GSFLEX 0.015 0.015 1 0.225 0.195 0.015
PGM2 PGM3 0.015 0.03 0.015 0.015 0.015
PGM2 MiSeq2 1 1 1 1 1 1
PGM2 MiSeq1 1 1 1 1 1 0.15
PGM2 GSFLEX 0.015 0.015 0.33 0.03 0.015 0.015
PGM2 PGM1 0.36 0.435 1 1 1 1
PGM3 PGM1 0.015 0.015 0.075 0.015 0.105 0.015
PGM3 GSFLEX 1 1 1 1 1 1
PGM3 MiSeq1 0.015 0.015 0.015 0.015 0.015 0.015
PGM3 MiSeq2 0.045 0.03 0.015 0.015 0.015 0.015
P
LA
T
F
O
R
M
GSFLEX MiSeq1 0.075 0.195 0.09 0.105 0.03 0.03
GSFLEX MiSeq2 1 1 1 1 0.36 0.93
MiSeq1 MiSeq2 0.015 0.015 0.105 0.225 0.075 0.015
PGM1 MiSeq2 1 1 1 1 1 1
PGM1 MiSeq1 0.015 0.015 1 1 0.705 0.195
PGM1 GSFLEX 1 1 1 1 1 1
PGM2 PGM3 0.18 0.165 0.03 0.03 0.105 0.06
PGM2 MiSeq2 1 1 1 1 1 1
PGM2 MiSeq1 0.255 0.255 0.015 0.015 0.015 0.015
PGM2 GSFLEX 1 1 0.09 0.285 1 1
PGM2 PGM1 0.015 0.03 1 1 1 1
PGM3 PGM1 0.015 0.03 1 1 1 1
PGM3 GSFLEX 0.3 0.225 0.015 0.015 0.015 0.015
PGM3 MiSeq1 1 1 0.06 0.03 0.075 0.09
PGM3 MiSeq2 0.015 0.015 0.015 0.03 0.015 0.015
(A)
(B)
ANALYSIS PIPELINE
P
LA
T
F
O
R
M
Phylogenetic Diversity
Species Richness
Fig. 3 A comparison of phylogenetic diversity (PD) and species richness (S) between the 6 runs (GS FLX, MiSeq1, MiSeq2, PGM1, PGM 2 and
PGM3) and in each pipeline a Phylogenetic diversity b Species Richness. Panels on the right show a matrix comparison between pipelines.
Numbers within cells indicate P-values >0.05 < 0.1. *P < 0.01,**P < 0.001
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PGM3 generated diversity values were significantly dif-
ferent to the Illumina, GS FLX+ and standard PGM
runs. Interestingly, significant differences were observed
in the number of species detected between the Miseq1
and Miseq2 runs, which were intended to test reproduci-
bility, when data was applied through QIIME1, QIIME2,
and UPARSE2 pipelines. We did not observe overall
statistical significant differences in phylogenetic diversity
or number of species due to treatment, time, or chicken
within any of the platforms.
Overall microbiome composition of samples
Analysis of Similarities (ANOSIM) and Permutational
Multivariate Analysis of Variance (PERMANOVA) ana-
lyses were performed on Unweighted Unifrac data to
evaluate differences between the 6 runs and bioinformat-
ics pipelines. We did not observe clustering by sequen-
cing platform (Additional file 2: Figure S1) but instead
samples grouped according to their corresponding ex-
perimental treatment group regardless of the sequencing
platform and bioinformatics pipelines (Fig. 4a). Principal
Coordinates Analysis (PCoA) of samples also showed
two sub clusters in the prebiotics group, which are most
probably associated with different time points in the
course of this experiment. Similar results were observed
in the Principal Coordinates Analysis (PCoA) based on
Weighted Unifrac matrices (not shown).
Procrustes analysis allowed us to determine whether
the same conclusions could be made from different β-
diversity analyses regardless of which platform was used
to compare the samples. Although Procrustes analysis of
data generated in the three platforms (GS FLX+, MiSeq1
and PGM1) analyzed using the QIIME2 pipeline (de
novo OTU picking plus chimera depletion) showed sub-
stantial differences (Monte Carlo p < 0.01 and high M2
values) (Fig. 4b), these differences were not as large as
the differences observed between treatments groups.
This analysis suggests that in spite of differences in the
β-diversity, all platforms were capable of discriminating
between treatments.
Microbiome composition was impacted by platform and
bioinformatics pipeline
Operational Taxonomic Units (OTUs) were identified at
a 97% similarity cut-off in the QIIME and UPARSE pipe-
lines. The number of sequences assigned to OTUs for
GS FLX+ was similar in all bioinformatics pipelines
(99%). De novo (QIIME1 and QIIME2) versus open-
reference OTU picking impacted the number of assigned
sequences for Illumina MiSeq runs but not for GS FLX+
runs. QIIME1 and QIIME2, both using UCLUST for de
novo OTU picking, and UPARSE1 and UPARSE2, both
using USEARCH for open reference OTU picking, re-
sulted in a higher number of unassigned reads from the
Illumina MiSeq generated data (ranging from 3.6 to
4.1%). Marginal differences were observed in the OTU
assignment between the three PGM runs in all bioinfor-
matics pipelines. PGM3 (same annealing temperature,
50 °C, and a reduced number of cycles from 35 to 25)
showed a Firmicutes abundance of almost 99%, while
PGM1 and PGM2 ranged from 96.8% to 98.7%. How-
ever, this difference was exaggerated when comparing
Vaccinated and Vaccinated-Challenged samples, with
Firmicutes dropping as low as 72.8% for PGM3 vs 90.3%
for PGM2. (Additional file 1: Table S2).
Firmicutes and Bacteroidetes were the most repre-
sented phyla in QIIME and UPARSE pipelines. GS FLX+
generated data showed the highest abundance of Firmi-
cutes with an average of 96.2% followed by the MiSeq
platform with an average of 93.2%, and PGM with
91.8%. Bacteroidetes were detected at 3% by GS FLX+,
2.3% by the MiSeq platform, and 6.4% by PGM. Proteo-
bacteria and Tenericutes were represented in low abun-
dance in all platforms and pipelines; however, they were
significantly (Kruskal-Wallis P ≤ 0.01) over represented
in the MiSeq generated data compared to PGM and GS
FLX+.
Distinct differences were observed between platforms and
pipelines in the relative abundance of specific genera (Fig. 5).
Overall, the QIIME pipelines generated a different bacterial
profile compared to the UPARSE pipeline with a clear im-
pact of the chimera depletion on relative abundance of bac-
terial taxa. GS FLX+ resulted in an over representation of
Eubacterium cylindroides compared to the other platforms
and protocols. Modification of PCR protocols in the PGM
runs also had an impact on this taxa as well as on detection
of Butyricicoccus pullicaecorum, a butyrate producer
thought to exert anti-inflammatory effects [57] and Oscillos-
pira, a genus highly represented in the data generated by
the PGM platform and analyzed by the QIIME pipeline
with no chimera depletion (QIIME1). The open reference
OTU picking pipelines (QIIME3 and QIIME4) generated a
differential representation of unclassified Erysipelotricha-
ceae (specifically over represented in PGM1), Turicibacter
(highly prevalent in the Illumina runs), and potential Rumi-
nococcus species. Taxa differentially represented by platform
in the UPARSE pipelines included Turicibacter, unclassified
Clostridiaceae, Clostridiales (highly prevalent in the PGM
pipelines), Eubacterium biforme, Lactobacillus spp., unclas-
sified Erysipelotrichaceae, Ruminococcus, Anaerotruncus,
and Lachnospiraceae.
Further analysis using PhyloToAST [54] (Fig. 6)
showed that the de novo OTU picking approach in the
QIIME pipeline identified the highest number of unique
species (over 250) followed by the open reference OTU
picking approach (approximately 180) and UPARSE (ap-
proximately 140). Relevant groups under detected by the
open reference and UPARSE OTU picking approaches
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included Bifidobacterium spp. (absent in the open refer-
ence and UPARSE OTU picking approaches) and Bifido-
bacterium adolescentis (not identified by UPARSE).
Differences in the detection profiles were also observed
for lactobacilli. Bifidobacteria and lactobacilli are of sig-
nificance for the samples analyzed in this study since
these populations are expected to be impacted by pre-
biotic feeding, one of the conditions analyzed. Other
taxa differentially identified by the different pipelines in-
cluded species of Tepidimicrobium, Thermacetogenium,
Tindallia_Anoxynatronum, and Tissierella_Soehngenia.
These groups correspond to poorly characterized soil
bacteria.
Finally, comparing the results of the pipelines intended
to assess finer resolution features of the microbial com-
munities, we found that the conclusions obtained in the
previous analyses largely hold. For both pipelines, sam-
ples clustered in beta diversity PCoA plots according to
treatment and sequencing run. Procrustes analysis
showed that the primary difference in taxa assessments
occurred due to the OTU/variant selection rather than
the mechanism of assigning taxa to individual sequence
representatives (Fig. 7a). The number of OTUs or se-
quence representatives produced by DADA2 was smaller
than the number of OTUs obtained from de novo OTU
picking with at 99% similarity threshold (Fig. 7b). At the
QIIME1
ANOSIM R=0.4946, P=0.001, 
PERMANOVA F=7.2165, P=0.001, 
QIIME2
ANOSIM p=0.001, R=0.4998
PERMANOVA p=0.001, F=7.3045 
QIIME3
ANOSIM p=0.001, R=0.5015 
PERMANOVA p=0.001, F=8.4217 
QIIME4
ANOSIM p=0.001, R=0.5052
PERMANOVA p=0.001, F=8.6540
UPARSE1
ANOSIM p=0.001, R=0.5768
PERMANOVA p=0.001, F=10.1628 
UPARSE2
ANOSIM p=0.001, R=0.5554 
PERMANOVA p=0.001, F=9.4836 
Control-Challenged Vaccinated Vaccinated - Challenged Prebiotics Prebiotics-Challenged
Monte Carlo p < 0.01
M2= 0.387 
Monte Carlo p < 0.01
M2= 0.482
Monte Carlo p < 0.01
M2= 0.345
GS FLEX – MiSeq1 GS FLEX – PGM1 MiSeq– PGM1
(A)
(B)
Fig. 4 a Principal Coordinates Analysis PCoA (Unweighted UniFrac) plots of data generated by the three different platforms, analyzed by different
bioinformatics pipelines and colored according to treatment group (Prebiotics, control and Salmonella-vaccinated). PERMANOVA F and P values
and ANOSIM R and P values are indicated. b Procrustes analysis of sequencing data from the different platforms analyzed with the QIIME2 (de novo
OTU picking plus chimera depletion). M and P values are indicated in the figure
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genus level or lower, the pipeline using QIIME for both
OTU picking and taxonomic assignment identified a total
of 166 different taxa, while the pipeline using DADA2 for
sequencing error suppression and taxonomic assignment
detected 138 (Additional file 3: Table S3), with 65 groups
identified at the species level. However, we observed that
the taxonomy profiles determined by two different se-
quence representative selecting algorithms were similar
and impacted mainly by the treatment. For the sequencing
results produced by the Illumina MiSeq platform, both
bioinformatic approaches support essentially the same
biological conclusions.
Discussion
Next Generation Sequencing (NGS) has revolutionized
the field of microbiome research [58–63]. Over the
course of the last decade, NGS has become a faster,
more accurate, and cost effective tool for the study of
complex microbial communities [64]. In this study, with
the objective of determining project-specific impacts of
sequencing platforms and bioinformatics pipelines, we
compared 16S rRNA amplicon sequencing data
generated using three different platforms and 7 bioinfor-
matics pipelines. GS FLX+, the traditional “gold stand-
ard” in terms of sequence length and quality prior to the
development of Illumina and Life Sciences technologies,
still generated the longest reads with the highest mean
quality score per read after filtering, but this platform
was not cost effective compared to newer platforms. Illu-
mina MiSeq generated the highest number of reads per
run but exhibited a lower mean quality score when com-
pared to Roche GS FLX+. The Ion Torrent PGM plat-
form yielded lower quality reads than MiSeq, and
therefore fewer usable reads after quality filtering; how-
ever, performance was within the manufacturer’s
parameters.
PCR-based high throughput amplicon sequencing in-
troduces biases to the results obtained, regardless of the
sequencing platform [16, 50]. In this study, Ion Torrent
PGM sequencing was performed on amplicon libraries
generated from three different PCR conditions (Fig. 1).
Modification of the PCR protocols for generation of se-
quencing libraries on the PGM platform directly im-
pacted the number of identified species and sample
QIIME1 QIIME2 QIIME3 QIIME4 UPARSE1 UPARSE2
GS FLEX Illumina1 Illumina2 PGM1 PGM2 PGM3
Fig. 5 Selected differences in relative abundances of the most impacted taxa according to data generated by different platforms (indicated by
different colors) and bioniformatic analysis pipelines (indicated across the top). The full figure can be seen in Additional file 2: Figure S2
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diversity. Our results clearly indicate that modifications
to the PCR conditions result in a differential representa-
tion of specific taxa. An increased number of PCR cycles
probably increased amplification of background DNA and
decreased specificity, as a lower annealing temperature.
This is an important issue when analyzing low biomass
samples, especially considering that DNA contamination
of reagents and laboratory-grade water has been clearly
demonstrated [65]. Other parameters that can impact taxa
identification and relative quantification are DNA input
and chosen amplification primers. The DNA input for the
GS FLX+ and PGM standard protocols is 4 times greater
than the input for amplicon generation for sequencing on
the MiSeq instrument following the standard protocol.
This could account for differences observed in the relative
abundance of bacterial taxa since the less abundant bac-
terial DNA will have greater chances to be amplified when
the amount of DNA is higher. No previous studies have
compared DNA input on 16S rRNA sequencing data gen-
eration, although the DNA isolation procedure has been
shown to have a significant impact on sequencing results
[66]. Previous studies have shown an impact of the primer
sets on 16S rRNA amplicon sequencing [26, 67]. In this
study we evaluated the same set of primers for all amplifi-
cations (8F and 338R); however, a potential impact of
adapters and barcodes specific to each platform added to
the sequencing primers cannot be discarded. Moreover,
primers targeting the V4 region of the 16S rRNA gene are
currently the most widely used; however, our project ini-
tially used the 454 platform for amplicon sequencing ana-
lysis. Since the region V1-V2 was the most traditionally
used across decades of research, and was reported optimal
specifically for 16S rRNA amplicon pyrosequencing across
a range of taxonomic classifications from phylum to fam-
ily [68], we chose to target such region. We are aware,
however, that recent studies provide support to targeting
the V3-V4 regions of the 16S rRNA gene for studies of
bacterial diversity and this is currently standard in our la-
boratory. We targeted the same region across platforms
for the sake of comparison. Finally, standard library prep-
aration protocols (GS-FLX+, PGM1, and MiSeq1/MiSeq2)
coupled with the most widely used bioinformatics analysis
procedure (QIIME2 = de novo OTU picking with removal
of chimeras) showed a significant difference in PD be-
tween GS-FLX+ and PGM1, and in the number of identi-
fied species between the two MiSeq runs between PGM1
and MiSeq1.
Different sequencing platforms/pipelines generate re-
sults with differing phylogenetic distributions (Fig. 5). As
the sequencing chemistry differs between platforms,
introducing internal biases, this finding is not without
precedent [23–25, 69–71]. Furthermore, microbial
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Fig. 6 Unique species identified by the different bioinformatic analysis schemes. Boxes indicate taxa not detected by open reference OTU picking
(QIIME) and UPARSE methods, which may be of significance for the study
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genera often vary drastically in genome composition. For
example, Lactobacillus reuteri has a GC content of
35.9%–38.9% [72] while Bifidobacterium longum has GC
content of 60% [73]. This difference in genomic GC con-
tent impacts the ability of different platforms to accur-
ately identify presence or absence, and to determine
microbial abundance. As such, biases introduced as a re-
sult of the sequencing chemistry, and limitations of indi-
vidual platforms to discriminate between microbes with
varying genomic GC content makes it important to con-
sider the technology used in relation to the scope of the
project. Our study showed that UPARSE analysis yields
fewer microbial genera and lower phylogenetic diversity
than QIIME analysis (Fig. 3a, Fig. 6). Both UPARSE and
QIIME pipelines start by quality-filtering reads, trim-
ming them to a fixed length, optionally discarding
singleton reads, and clustering the remaining reads. The
differences between the two pipelines rely on the cluster-
ing algorithm. UPARSE uses a ‘greedy’ algorithm that
performs chimera filtering and OTU clustering
simultaneously, while QIIME performs chimera filtering
as a separate step. In this study we evaluated both the de
novo and open reference OTU picking in QIIME. The
main advantage of the first method is that it does not re-
quire a collection of reference sequences before working
with a new marker gene. The open-reference OTU pick-
ing combines closed-reference OTU picking, in which
input sequences are aligned to pre-defined cluster cen-
troids in a reference database, and if the input sequence
does not match any reference sequence at a defined per-
cent identity threshold, the sequence is excluded, and de
novo OTU picking is applied to the remaining se-
quences. The OTU picking algorithm used by UPARSE
does not require technology- or gene-specific parameters
(such as an OTU size cutoff ), algorithms (such as flow-
gram denoising) or data (such as a curated multiple
alignment) [37]. The impact of different bioinformatics
pipelines on the diversity captured from specific micro-
bial ecosystems was investigated in Pylro et al. [56]. The
study concluded that UniFrac distances between samples
DADA2.DADA2/DADA2.QIIME DADA2.DADA2/QIIME.QIIMEDADA2.QIIME/ QIIME.DADA2 QIIME.QIIME/ QIIME.DADA2
(A)
(B) (D)
Control PrebioticsVaccinated
(C)
Control_run1
Control_run2
Vaccinated_run1
Vaccinated_run2
Prebiotics_run1
Prebiotics_run2
Vaccinated
Fig. 7 Comparisons made between the two different OTU/variant calling (either DADA2 or QIIME de novo OTU picking at 99% similarity) and the
two different taxa assigment algorithms (DADA2 or QIIME using the Greengenes database). Labels are: QIIME.QIIME indicating QIIME was used for
OTU picking and taxonomic assigment, QIIME.DADA2 indicating QIIME was used for OTU picking and DADA2 was used for taxonomic assignment,
DADA2.QIIME indicating the DADA2 was used for sequencing error supression and QIIME was used for taxonomic assignment, and DADA2.DADA2
indicating that used for both sequencing error suppresion and taxonomic assignment. a Procrustes analysis. b A comparison of the number of OTUs
identified by DADA2 (clear boxes) and QIIME de novo OTU picking at 99% similarity (shaded boxes).c Taxonomic profiles of samples grouped by
treatment and bioinformatics pipeline. Only major taxa are indicated in the Figure. d Correlation analysis of relative abundances of bacterial taxa at
species level. For a complete list see Additional file 3: Table S3
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sequenced on both Illumina MiSeq and PGM were sig-
nificantly correlated.
Procrustes analysis of data showed clear differences be-
tween data generated from each platform (Fig. 4b and 7a).
Nevertheless, despite differences in platform sequencing
performance and data output, all three platforms were
capable of discriminating samples by treatment and led us
to similarly valid biological conclusions (Fig. 4a). Our re-
sults are in agreement with a previous study that showed
that soil samples analyzed by 16S rRNA sequencing using
either the Illumina MiSeq or PGM platforms clustered by
site rather than by sequencing platform [56].
Determining the most accurate and appropriate ap-
proaches to generate and analyze sequencing data from
complex microbial communities remains an important
goal of researchers focused on microbiota studies. Un-
fortunately without a standardized set of protocols from
sample preparation and handling to final data analysis
(and every step in between), it is impossible to eliminate
biases from these studies entirely. However, making an
effort to choose the correct sequencing platform for a
given study as well as the most appropriate data analysis
tools will drastically reduce errors in data acquisition
and processing between studies. In this context, emer-
ging analysis methods (methods that attempt to differen-
tiate between sequences with similarity greater than the
97% convention) such as DADA2 [38] and Oligotyping
[74] are an innovative and interesting new development
in the processing of sequencing of microbial communi-
ties. These methods differ from conventional methods in
substantial ways, for example, the suppression of se-
quencing errors and estimation of their probability dis-
tribution. These matters are of fundamental importance
to methods that attempt to differentiate biologically
meaningful single nucleotide variation from sequencing
data and warrant ongoing comparisons of relevant pro-
tocols and analysis methods for the study of complex
microbial communities.
In our study, we compared DADA2 [38] and QIIME
de novo OTU picking with a similarity threshold of 99%
for OTU or variant calling, and then assignment of tax-
onomy was performed on each table using either the
DADA2 taxonomy classification method and the QIIME
taxonomy classification method. As with UPARSE, ap-
plying the DADA2 variant calling pipeline resulted in
lower numbers of identified OTUs, resulting in signifi-
cant differences between pipelines demonstrated by the
Procrustes analysis. However, both pipelines resulted in
clustering of samples by treatment and Illumina run.
Moreover, a linear correlation analysis comparing rela-
tive abundances determined by the pipeline using
QIIME for both OTU picking and taxonomic assign-
ment and the pipeline using DADA2 for both sequen-
cing error suppression and taxonomic assignment
showed a Person’s r value of 0.93 indicating a strong
correlation between values (Fig. 7d). Although applica-
tion of the DADA2 algorithm for taxonomy assignment
resulted in a higher number of species identified, reli-
ability on the assignment at sub genus level is largely
unknown since this software has not been extensively
tested and was developed with a mock community of
known bacterial strains as opposed to be done on native
communities. As such, use of this software for analysis
of gut microbial communities should be done with cau-
tion. Traditional microbiology methods and whole gen-
ome shotgun sequencing data will confirm or deny
whether single nucleotide polymorphisms of a single
bacterial gene are sufficient to obtain reliable species
level information within complex communities.
Conclusion
Our study confirmed differences between sequencing plat-
forms and library preparation protocols in the determin-
ation of microbial diversity and species richness.
Moreover, we showed that bioinformatics pipelines used
to analyze sequence data yielded results that differ de-
pending on specific parameters. However, we concluded
that, specifically for our chicken-Salmonella infection
study, despite these differences, samples from variable
treatment groups were differentiated from one another re-
gardless of the sequencing platform and/or bioinformatics
pipeline used allowing us to draw similar conclusions.
This suggested that the same biological conclusions could
be drawn from data, as long as the data is collected and
analyzed consistently throughout the course of the experi-
ment. It is critical for researchers to take into consider-
ation the limitations of each sequencing platform, and
choose a system appropriate for their experimental design.
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